Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab.

The Journal of dermatology - 1 Mar 2022

Kanatani Yushi, Shinkuma Satoru, Matsumoto Yuka, Mitsui Yasuhiro, Shobatake Chinatsu, Ogawa Kohei, Miyagawa Fumi, Sugiura Kazumitsu, Asada Hideo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Interleukins
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pregnancy

Share to Pregnancy Complications

Share to Psoriasis

Source

Identifiers

PMID: 34806229
DOI: 10.1111/1346-8138.16247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab.PMID 34806229Read ↗

Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.Semantic proximity Read ↗

IL36RN mutations underlie impetigo herpetiformis.Semantic proximity Read ↗

Impetigo herpetiformis with IL36RN mutations in a Chinese patient: A founder haplotype of c.115+6T>C in East Asia.Semantic proximity Read ↗

Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: A case report and review of published cases.Semantic proximity Read ↗

Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.Semantic proximity Read ↗

Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.Semantic proximity Read ↗

Deficiency of the interleukin-36 receptor antagonist dramatically improved by secukinumab.Semantic proximity Read ↗

Spesolimab for generalized pustular psoriasis: a prospective study with a 6-month follow-up.Semantic proximity Read ↗

Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.Semantic proximity Read ↗

Use of biologics in Chinese pregnant patients with deficiency of interleukin-36 receptor antagonist (DITRA): A case series.Semantic proximity Read ↗

Recurrent pyoderma gangrenosum and cystic acne associated with leucocyte adhesion deficiency due to novel mutations in ITGB2: successful treatment with infliximab and adalimumab.Semantic proximity Read ↗

Annular pustular psoriasis with a heterozygous IL36RN mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.